Advertisement

Topic - Thermo Fisher

Related Stories

FILE - This April 26, 2007, file photo, shows the exterior of Thermo Fisher Scientific Inc., in Waltham, Mass. Thermo Fisher is buying clinical research company PPD in a deal valued at $17.4 billion. (AP Photo/Stephan Savoia, File)

Thermo Fisher buying PPD in deal worth $17.4 billion

Associated Press

Many steps needed for accurate COVID-19 test results

By MATTHEW PERRONE - Associated Press

FDA flags accuracy issue with widely used coronavirus test

By MATTHEW PERRONE - Associated Press

This April 26, 2007, file photo, shows the exterior of Thermo Fisher Scientific Inc., of Waltham, Mass. Thermo Fisher Scientific Inc., a maker of scientific instrument and laboratory supplies, is buying Qiagen in a deal valued at about $10.1 billion, reported Tuesday, March 3, 2020. Qiagen NV is a provider of molecular diagnostics and sample preparation technologies. The Netherlands-based company has approximately 5,100 workers at 35 locations in more than 25 countries. The deal is expected to close in the first half of 2021. (AP Photo/Stephan Savoia, File)

FDA issues coronavirus test alert

By Matthew Perrone - Associated Press

Adm. Brett Giroir, M.D., Assistant Secretary for Health, speaks during a briefing about the coronavirus in the James Brady Press Briefing Room of the White House, Sunday, March 15, 2020, in Washington. (AP Photo/Alex Brandon)

Gov’t virus testing will prioritize medical staff, elderly

By MATTHEW PERRONE - Associated Press

In this undated photo provided by Civica, Inc., former drug industry executive Martin VanTrieste poses for a photo. VanTrieste, who came out of retirement to run Civica without a salary, recently spoke with the Associated Press. (Purple Moss Photography/Civica, Inc. via AP)

Hospital group fights drug shortages by making needed meds

By LINDA A. JOHNSON - Associated Press

Cisco and Navistar tumble while Tyson and Dillard’s gain

Associated Press